These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6093453)

  • 1. Modulation of neuroreceptor functions by lipomodulin, a phospholipase inhibitory protein.
    Hirata F; Notsu Y; Matsuda K; Hattori T
    Adv Exp Med Biol; 1984; 175():187-92. PubMed ID: 6093453
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipomodulin: a possible mediator of the action of glucocorticoids.
    Hirata F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():73-8. PubMed ID: 6221579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein.
    Hattori T; Hirata F; Hoffman T; Hizuta A; Herberman RB
    J Immunol; 1983 Aug; 131(2):662-5. PubMed ID: 6223089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation.
    Hirata F
    J Biol Chem; 1981 Aug; 256(15):7730-3. PubMed ID: 6267023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.
    Hirata F; del Carmine R; Nelson CA; Axelrod J; Schiffmann E; Warabi A; De Blas AL; Nirenberg M; Manganiello V; Vaughan M; Kumagai S; Green I; Decker JL; Steinberg AD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3190-4. PubMed ID: 6114491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of a histiocytic lymphoma cell line by lipomodulin, a phospholipase inhibitory protein.
    Hattori T; Hoffman T; Hirata F
    Biochem Biophys Res Commun; 1983 Mar; 111(2):551-9. PubMed ID: 6838573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of phospholipase inhibitory proteins.
    Hirata F; Hirata A
    Adv Exp Med Biol; 1990; 279():211-8. PubMed ID: 2151416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin.
    Hirata F; Notsu Y; Iwata M; Parente L; DiRosa M; Flower RJ
    Biochem Biophys Res Commun; 1982 Nov; 109(1):223-30. PubMed ID: 7159423
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes.
    Hirata F; Iwata M
    J Immunol; 1983 Apr; 130(4):1930-6. PubMed ID: 6220071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin.
    Uede T; Hirata F; Hirashima M; Ishizaka K
    J Immunol; 1983 Feb; 130(2):878-84. PubMed ID: 6600257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of lipocortin (lipomodulin).
    Hirata F; Notsu Y; Yamada R; Ishihara Y; Wano Y; Kunos I; Kunos G
    Agents Actions; 1986 Jan; 17(3-4):263-6. PubMed ID: 3962767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of I-J determinants with lipomodulin/macrocortin.
    Jardieu P; Akasaki M; Ishizaka K
    Proc Natl Acad Sci U S A; 1986 Jan; 83(1):160-4. PubMed ID: 2417235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation at a tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytes.
    Hirata F; Matsuda K; Notsu Y; Hattori T; del Carmine R
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4717-21. PubMed ID: 6205401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 and lipocortin effects.
    Dennis EA; Davidson FF
    Prog Clin Biol Res; 1990; 349():47-54. PubMed ID: 2144646
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes of phospholipase A2 inhibitory activity in the K+-sensitive actin gelation factor during the differentiation of myeloid leukemia cells.
    Takagi K; Hotta H; Suketa Y
    Biochim Biophys Acta; 1987 Oct; 930(3):320-5. PubMed ID: 2958092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the biologic activities of IgE-binding factors. VII. Biochemical mechanisms by which glycosylation-enhancing factor activates phospholipase in lymphocytes.
    Akasaki M; Iwata M; Ishizaka K
    J Immunol; 1985 Jun; 134(6):4069-77. PubMed ID: 3872909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin".
    Rothhut B; Russo-Marie F; Wood J; DiRosa M; Flower RJ
    Biochem Biophys Res Commun; 1983 Dec; 117(3):878-84. PubMed ID: 6667275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a lipocortin-like 33 kDa protein from guinea pig neutrophils.
    Sato EF; Miyahara M; Utsumi K
    FEBS Lett; 1988 Jan; 227(2):131-5. PubMed ID: 2962884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of leukocyte chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly.
    Hirata F; Notsu Y; Matsuda K; Vasanthakumar G; Schiffmann E; Wong TW; Goldberg AR
    Biochem Biophys Res Commun; 1984 Jan; 118(2):682-90. PubMed ID: 6704100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipocortin, a protein controlling membrane activation in the inflammatory reaction].
    Russo-Marie F
    Pathol Biol (Paris); 1986 Apr; 34(4):227-33. PubMed ID: 2944064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.